Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants

Journal of Virology

Volumn 76, Issue 14, 2002, Pages 6929-6943

  Pedroza Martins, Livia ^a   Boscardin, W John ^a   Anisman Posner, Deborah J ^a   Schols, Dominique ^b   Bryson, Yvonne J ^a   Uittenbogaart, Christel H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; CD27 ANTIGEN; INTERLEUKIN DERIVATIVE;

ARTICLE; CELL MATURATION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE; THYMUS; THYMUS DISEASE; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

HIV TYPE 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD27; CELL DIFFERENTIATION; CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKINS; RECEPTORS, CCR5; RECEPTORS, CXCR4; T-LYMPHOCYTES; THYMUS GLAND; VIRUS REPLICATION;

EID: 0036634211     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.14.6929-6943.2002     Document Type: Article

References (88)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Aldrovandi, G. M., G. Feuer, L. Gao, B. Jamieson, M. Kristeva, I. S. Y. Chen, and J. A. Zack. 1993. The SCID-hu mouse as a model for HIV-1 infection. Nature 363:732-736.
3. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
4. Berkowitz, R. D., K. P. Beckerman, T. J. Schall, and J. M. McCune. 1998. CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T-cell differentiation. J. Immunol. 161:3702-3710.
5. Blanche, S., M. Tardieu, A. Duliege, et al. 1990. Longitudinal study of 94 symptomatic infants with perinatally acquired HIV infection. Evidence for bimodal expression of clinical and biological symptoms. Am. J. Dis. Child. 144:1210-1215.
6. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925-1930.
7. Boyer, P. J., M. Dillon, M. Navaie, A. Deveikis, M. Keller, S. O'Rourke, and Y. J. Bryson. 1994. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 271:1925-1930.
8. Bridger, G. J., R. T. Skerlj, S. Padmanabhan, S. A. Martellucci, G. W. Henson, S. Struyf, M. Witvrouw, D. Schols, and E. De Clercq. 1999. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4. J. Med. Chem. 42:3971-3981.
9. Buseyne, F., G. Janvier, J. P. Teglas, S. Ivanoff, M. Burgard, E. Bui, M. J. Mayaux, S. Blanche, C. Rouzioux, and Y. Riviere. 1998. Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age. J. Infect. Dis. 178:1019-1023.
10. + thymocytes: a critical role for tumor necrosis factor and interleukin-7. J. Virol. 73:7533-7542.
11. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat. Med. 5:651-655.
12. + T cells. Proc. Natl. Acad. Sci. USA 98:9277-9282.
13. + T-cell lines determined by the capacity to exploit low concentrations of CCR5. J. Virol. 73:7842-7847.
14. Dickover, R. E., M. Dillon, K. M. Leung, P. Krogstad, S. Plaeger, S. Kwok, C. Christopherson, A. Deveikis, M. Keller, E. R. Stiehm, and Y. J. Bryson. 1998. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J. Infect. Dis. 178:375-387.
15. Dickover, R. E., E. M. Garratty, S. Plaeger, and Y. J. Bryson. 2001. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J. Virol. 75:2194-2203.
16. Douek, D. C., R. A. Koup, R. D. McFarland, J. L. Sullivan, and K. Luzuriaga. 2000. Effect of HIV on thymic function before and after antiretroviral therapy in children. J. Infect. Dis. 181:1479-1482.
17. Edelstein, R. E., L. A. Arcuino, J. P. Hughes, A. J. Melvin, K. M. Mohan, P. D. King, C. L. McLellan, B. L. Murante, B. P. Kassman, and L. M. Frenkel. 1997. Risk of mother-to-infant transmission of HIV-1 is not reduced in CCR5/Δ32ccr5 heterozygotes. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:243-246.
18. Fais, S., C. Lapenta, S. M. Santini, M. Spada, S. Parlato, M. Logozzi, P. Rizza, and F. Belardelli. 1999. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. J. Virol. 73:6453-6459.
19. + lymphocyte activity. J. Infect. Dis. 172: 329-339.
20. Franz-Bacon, K., D. J. Dairaghi, S. A. Boehme, S. K. Sullivan, T. J. Schall, P. J. Conlon, N. Taylor, and K. B. Bacon. 1999. Human thymocytes express CCR-3 and are activated by eotaxin. Blood 93:3233-3240.
21. Fry, T. J., E. Connick, J. Falloon, M. M. Lederman, D. J. Liewehr, J. Spritzler, S. M. Steinberg, L. V. Wood, R. Yarchoan, J. Zuckerman, A. Landay, and C. L. Mackall. 2001. A potential role for interleukin-7 in T-cell homeostasis. Blood 97:2983-2990.
22. + cells in the human thymus are defined by expression of CD34: delineation of early events in human thymic development. J. Exp. Med. 178:391-401.
23. Ganeshan, S., R. E. Dickover, B. T. Korber, Y. J. Bryson, and S. M. Wolinsky. 1997. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J. Virol. 71:663-677.
24. Gaulton, G. N., J. V. Scobie, and M. Rosenzweig. 1997. HIV-1 and the thymus. AIDS 11:403-414.
25. Gerlach, L. O., R. T. Skerlj, G. J. Bridger, and T. W. Schwartz. 2001. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J. Biol. Chem. 276:14153-14160.
26. Greco, G., S. H. Fujimura, D. V. Mourich, and J. A. Levy. 1999. Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation. J. Virol. 73:1528-1534.
27. Grivel, J. C., and L. B. Margolis. 1999. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat. Med. 5:344-346.
28. + thymocytes through sustained induction of Bcl-2. Blood 98: 2166-2174.
29. Haynes, B. F., M. L. Markert, G. D. Sempowski, D. D. Patel, and L. P. Hale. 2000. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu. Rev. Immunol. 18:529-560.
30. Imai, T., M. Baba, M. Nishimura, M. Kakizaki, S. Takagi, and O. Yoshie. 1997. The T cell-directed CC chemokine TARC is a highly specific biological ligand for the CC chemokine receptor 4. J. Biol. Chem. 272:15036-15042.
31. Jamieson, B. D., G. M. Aldrovandi, V. Planelles, J. B. M. Jowett, L. Gao, L. Bloch, I. S. Y. Chen, and J. A. Zack. 1994. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68:3478-3485.
32. Jamieson, B. D., S. Pang, G. M. Aldrovandi, J. Zha, and J. A. Zack. 1995. In vivo pathogenic properties of two clonal HIV-1 isolates. J. Virol. 69:6259-6264.
33. Jourdan, P., C. Abbal, N. Noraz, T. Hori, T. Uchiyama, J. P. Vendrell, J. Bousquet, N. Taylor, J. Pene, H. Yssel, and N. Nora. 1998. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J. Immunol. 160:4153-4157.
34. Kaneshima, H., L. Su, M. L. Bonyhadi, R. I. Connor, D. D. Ho, and J. M. McCune. 1994. Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J. Virol. 68:8188-8192.
35. Keir, M. E., C. A. Stoddart, V. Linquist-Stepps, M. E. Moreno, and J. M. McCune. 2002. IFN-alpha secretion by type 2 predendritic cells upregulates MHC class I in the HIV-1-infected thymus. J. Immunol. 168:325-331.
36. Kitchen, S. G., C. H. Uittenbogaart, and J. A. Zack. 1997. Mechanism of human imunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection. J. Virol. 71:5713-5722.
37. Kitchen, S. G., and J. A. Zack. 1997. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J. Virol. 71:6928-6934.
38. Koot, M., A. H. Vos, R. P. Keet, R. P. De Goede, M. W. Dercksen, F. G. Terpstra, R. A. Coutinho, F. Miedema, and M. Tersmette. 1992. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6:49-54.
39. Kourtis, A. P., C. Ibegu, A. J. Nahmias, F. K. Lee, W. S. Clark, M. K. Sawyer, and S. Nesheim. 1996. Early progression of disease in HIV-infected infants with thymus dysfunction. N. Engl. J. Med. 335:1431-1436.
40. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merill, H. V. Vinters, and I. S. Y. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
41. Landay, A. L., B. Patterson, and J. Andersson. 1999. Cytokine modulation of HIV-1 chemokine receptor expression. Nat. Med. 5:592-593.
42. Lee, B., M. Sharron, C. Blanpain, B. J. Doranz, J. Vakili, P. Setoh, E. Berg, G. Liu, H. R. Guy, S. R. Durell, M. Parmentier, C. N. Chang, K. Price, M. Tsang, and R. W. Doms. 1999. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J. Biol. Chem. 274:9617-9626.
43. Lee, B., M. Sharron, L. J. Montaner, D. Weissman, and R. W. Doms. 1999. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA 96:5215-5220.
44. Lee, S., H. L. Tiffany, L. King, P. M. Murphy, H. Golding, and M. B. Zaitseva. 2000. CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor. J. Virol. 74:6946-6952.
45. Liao, F., G. Alkhatib, K. W. C. Peden, G. Sharma, E. A. Berger, and J. M. Farber. 1997. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T-cell line-tropic HIV-1. J. Exp. Med. 185:2015-2023.
46. Littell, R. C., G. A. Milliken, W. W. Stroup, and R. D. Wolfinger. 1996. SAS system for mixed models. SAS Institute, Inc., Cary, N.C.
47. Lusso, P. 2000. Chemokines and viruses: the dearest enemies. Virology 273:228-240.
48. Mackall, C. L., F. T. Hakim, and R. E. Gress. 1997. T-cell regeneration: all repertoires are not created equal. Immunol. Today 18:245-251.
49. Mikyas, Y., N. Aziz, N. Harawa, M. Gorre, N. Neagos, M. Nogueira, D. Wafer, M. Dillon, P. J. Boyer, Y. J. Bryson, and S. Plaeger. 1997. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J. Reprod. Immunol. 33:157-170.
50. Nahmias, A. J., W. S. Clark, A. P. Kourtis, F. K. Lee, G. Cotsonis, C. Ibegbu, D. Thea, P. Palumbo, P. Vink, R. J. Simonds, S. R. Nesheim, et al. 1998. Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. J. Infect. Dis. 178:680-685.
51. Napolitano, L. A., R. M. Grant, S. G. Deeks, D. Schmidt, S. C. De Rosa, L. A. Herzenberg, B. G. Herndier, J. Andersson, and J. M. McCune. 2001. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 7:73-79.
52. Napolitano, M., A. Zingoni, G. Bernardini, G. Spinetti, A. Nista, C. T. Starlazzi, M. Rocchi, and A. Santoni. 1996. Molecular cloning of TER-1, a chemokine receptor-like gene expressed by lymphoid tissues. J. Immunol. 157:2759-2763.
53. Ostrowski, M. A., S. J. Justement, A. Catanzaro, C. A. Hallahan, L. A. Ehler, S. B. Mizell, P. N. Kumar, J. A. Mican, T. W. Chun, and A. S. Fauci. 1998. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J. Immunol. 161:3195-3201.
54. Papiernik, M., Y. Brossard, N. Milliez, J. Roume, C. Brechot, F. Barin, A. Goudeau, J.-F. Bach, C. Griscelli, R. Henrion, and R. Vazeux. 1992. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics 89:297-301.
55. Patterson, B. K., M. Czerniewski, J. Andersson, Y. Sullivan, F. Su, D. Jiyamapa, Z. Burki, and A. Landay. 1999. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin. Immunol. 91:254-262.
56. Pedroza-Martins, L., K. B. Gurney, B. E. Torbett, and C. H. Uittenbogaart. 1998. Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level. J. Virol. 72:9441-9452.
57. Res, P., and H. Spits. 1999. Developmental stages in the human thymus. Semin. Immunol. 11:39-46.
58. Romiti, M. L., C. Colognesi, C. Cancrini, A. Mas, M. Berrino, F. Salvatori, P. Orlandi, M. Jansson, E. Palomba, A. Plebani, J. M. Bertran, M. Hernandez, M. de Martino, A. Amoroso, P. A. Tovo, P. Rossi, T. Espanol, and G. Scarlatti. 2000. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection. Mol. Med. 6:28-36.
59. Scadden, D. T. 1997. Cytokine use in the management of HIV disease. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 16(Suppl. 1):S23-S29.
60. Scarlatti, G., T. Leitner, V. Hodara, E. Halapi, P. Rossi, J. Albert, and E. M. Fenyo. 1993. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. AIDS 7(Suppl. 2):S45-S48.
61. Scarlatti, G., E. Tresoldi, A. Bjorndal, R. Fredriksson, C. Colognesi, H. K. Deng, M. S. Malnati, A. Plebani, A. G. Siccardi, D. R. Littman, E. M. Fenyo, and P. Lusso. 1997. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1259-1265.
62. Schmid, I., C. H. Uittenbogaart, and J. V. Giorgi. 1991. A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry 12:279-285.
63. Schmid, I., C. H. Uittenbogaart, B. Keld, and J. V. Giorgi. 1994. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods 170:145-157.
64. Schols, D., and E. De Clercq. 2001. Cellular receptors as targets for antihuman immunodeficiency virus agents, p. 11-30. In E. De Clercq (ed.), Antiretroviral therapy. ASM Press, Washington, D.C.
65. Schols, D., S. Struyf, J. Van Damme, J. A. Este, G. Henson, and E. De Clercq. 1997. Inhibition of T-tropic HIV strains by selective antagonization of chemokine receptor CXCR4. J. Exp. Med. 186:1383-1388.
66. Scoggins, R. M., J. R. J. Taylor, J. Patrie, A. B. van't Wout, H. Schuitemaker, and D. Camerini. 2000. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. J. Virol. 74:3205-3216.
67. Shearer, W. T., C. Langston, D. E. Lewis, E. L. Pham, H. H. Hammill, C. A. Kozinetz, M. W. Kline, I. C. Hanson, and E. J. Popek. 1997. Early spontaneous abortions and fetal thymic abnormalities in maternal-to-fetal HIV infection. Acta Paediatr. Suppl. 421:60-64:60-64.
68. Shearer, W. T., J. Reuben, B. N. Lee, E. J. Popek, D. E. Lewis, H. H. Hammill, I. C. Hanson, M. W. Kline, and C. Langston. 1997. Role of placental cytokines and inflammation in vertical transmission of HIV infection. Acta Paediatr. Suppl. 421:33-38:33-38.
69. Singh, A., and R. G. Collman. 2000. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies. J. Virol. 74:10229-10235.
70. Smithgall, M. D., J. G. Wong, K. E. Critchett, and O. K. Haffar. 1996. IL-7 upregulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J. Immunol. 156:2324-2330.
71. Stanley, S. K., J. M. McCune, H. Kaneshima, J. S. Justement, M. Sullivan, E. Boone, M. Baseler, J. Adelsberger, M. Bonyhadi, J. Orenstein, C. H. Fox, and A. S. Fauci. 1993. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J. Exp. Med. 178:1151-1163.
72. Ueno, Y., E. Hays, L. Hultin, and C. H. Uittenbogaart. 1989. Human thymocytes do not respond to interleukin-2 after removal of mature "bright" CD5-positive cells. Cell. Immunol. 124:239-251.
73. Uittenbogaart, C. H., D. J. Anisman, B. D. Jamieson, S. Kitchen, I. Schmid, J. A. Zack, and E. F. Hays. 1996. Differential tropism of HIV-1 isolates for distinct thymocyte subsets in vitro. AIDS 10:F9-F16.
74. Uittenbogaart, C. H., D. J. Anisman, J. A. Zack, A. Economides, I. Schmid, and E. F. Hays. 1995. Effects of cytokines on HIV-1 production by thymocytes. Thymus 23:155-175.
75. Uittenbogaart, C. H., W. J. Boscardin, D. J. Anisman-Posner, P. S. Koka, G. Bristol, and J. A. Zack. 2000. Effect of cytokines on HIV-induced depletion of thymocytes in vivo. AIDS 14:1317-1325.
76. Uittenbogaart, C. H., S. Higashitani, I. Schmid, L. W. Vollger, T. Boone, and L. T. Clement. 1990. Interleukin-4 induces expression of the CD45RA antigen on human thymocyte subpopulations. Int. Immunol. 2:1179-1187.
77. Unutmaz, D., V. N. KewalRamani, S. Marmon, and D. R. Littman. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189:1735-1746.
78. Valentin, A., W. Lu, M. Rosati, R. Schneider, J. Albert, A. Karlsson, and G. N. Pavlakis. 1998. Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc. Natl. Acad. Sci. USA 95:8886-8891.
79. Verhasselt, B., E. Naessens, C. Verhofstede, M. De Smedt, S. Schollen, T. Kerre, D. Vanhecke, and J. Plum. 1999. Human immunodeficiency virus nef gene expression affects generation and function of human T cells, but not dendritic cells. Blood 94:2809-2818.
80. Vigano, A., S. Vella, N. Principi, D. Bricalli, N. Sala, A. Salvaggio, M. Saresella, A. Vanzulli, and M. Clerici. 1999. Thymus volume correlates with the progression of vertical HIV infection. AIDS 13:F29-F34.
81. Vigano, A., C. Balotta, D. Trabattoni, D. Bricalli, L. Crupi, E. Palomba, L. Galli, A. Salvaggio, M. L. Fusi, S. Ruzzante, E. Massironi, M. C. Colombo, N. Principi, M. Galli, and M. Clerici. 1997. Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts. Pathobiology 65:169-176.
82. Vigano, A., S. Vella, M. Saresella, A. Vanzulli, D. Bricalli, S. Di Fabio, P. Ferrante, M. Andreotti, M. Pirillo, L. G. Dally, M. Clerici, and N. Principi. 2000. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS 14:251-261.
83. von Seidlein, L., S. Plaeger, R. Dickover, P. Krogstad, E. R. Stiehm, and Y. Bryson. 1998. Primary human immunodeficiency virus type 1 infection during pregnancy associated with transmission of SI/MT-2 cell tropic virus and precipitous loss of CD4 cells in mother and infant. Pediatr. Infect. Dis. J. 17:528-530.
84. Wasik, T. J., J. Bratosiewicz, A. Wierzbicki, V. E. Whiteman, R. R. Rutstein, S. E. Starr, S. D. Douglas, D. Kaufman, A. V. Sison, M. Polansky, H. W. Lischner, and D. Kozbor. 1999. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J. Immunol. 162:4355-4364.
85. + lymphocytes in vivo. J. Infect. Dis. 181:933-938.
86. Yamamoto, H., T. Kishimoto, and S. Minamoto. 1998. NF-κB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27. J. Immunol. 161:4753-4759.
87. Yu, C. R., K. W. Peden, M. B. Zaitseva, H. Golding, and J. M. Farber. 2000. CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck β-15 that differ in their sensitivities to ligand. J. Immunol. 164:1293-1305.
88. Zaitseva, M. B., S. Lee, R. L. Rabin, H. L. Tiffany, J. M. Farber, K. W. Peden, P. M. Murphy, and H. Golding. 1998. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection. J. Immunol. 161:3103-3113.